組織検査の世界市場2016-2020

◆英語タイトル:Global Tissue Diagnostics Market 2016-2020
◆商品コード:IRTNTR8799
◆発行会社(リサーチ会社):Technavio
◆発行日:2016年2月24日
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、組織検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、組織検査の世界市場規模及び予測、技術別分析、製品別分析、需要先別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About Tissue Diagnostics

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

Technavio’s analysts forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:
• Advanced staining
• Preanalytical and routine staining
• Digital pathology

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Diagnostics
• Agilent Technologies (a parent company of Dako)
• Danaher (a parent company of Leica Biosystems)
• Roche Diagnostics

[Other prominent vendors]
• 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Affymetrix
• Agendia
• AutoGenomics
• AVIVA BioSciences
• Biocare Medical
• Biocartis
• Cancer Genetics
• ELITechGroup
• Enzo Biochem
• Epic Sciences
• Fluidigm
• HORIBA Medical
• Janssen Diagnostics
• Olympus Diagnostics Systems Group
• Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
• Oxford Gene Technology
• PANAGENE
• Protea Biosciences Group
• Sakura Finetek

[Market driver]
• Implementation by new customers
• For a full, detailed list, view our report

[Market challenge]
• Insurance coverage and reimbursement issues
• For a full, detailed list, view our report

[Market trend]
• Ready-to-use reagents
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Global cancer statistics

PART 06: Reimbursement and coverage: An overview
• Current scenario: Validating diagnostic tests
• Reimbursement structure in US
• Reimbursement structure in EU
• Prevailing issues of reimbursement policies

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by technology
• Global tissue diagnostics market by advanced staining
• Global tissue diagnostics market by digital pathology
• Global tissue diagnostics market by preanalytical and routine staining

PART 09: Market segmentation by product
• Global tissue diagnostics market segmentation by consumables
• Global tissue diagnostics market segmentation by instruments

PART 10: Market segmentation by disease
• Breast cancer
• Lung cancer
• Colorectal cancer
• Lymphoma
• Cervical cancer
• Prostate cancer
• Other diseases

PART 11: Market segmentation by end-user
• Hospitals
• CROs
• Academia and research institutes

PART 12: Geographical segmentation
• Tissue diagnostics market in Americas
• Tissue diagnostics market in EMEA
• Tissue diagnostics market in APAC

PART 13: Market drivers
• Prevalence of chronic diseases
• Implementation by new consumers
• Use of biomarkers for disease diagnosis
• Demand for personalized medicine

PART 14: Impact of drivers

PART 15: Market challenges
• Insurance coverage and reimbursement issues
• Limitations of closed systems
• High initial investment and maintenance costs

PART 16: Impact of drivers and challenges

PART 17: Market trends
• Ready-to-use reagents
• Focus on system automation
• Increase in M&A

PART 18: Vendor landscape
• Competitive scenario
• Market share analysis 2015

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Prevalent cancer types worldwide 2012
Exhibit 03: Countries with highest cancer rate 2012
Exhibit 04: Cancer statistics by gender 2012
Exhibit 05: Reimbursement perspectives of healthcare entities
Exhibit 06: Global tissue diagnostics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global tissue diagnostics market segmentation by technology
Exhibit 09: Global tissue diagnostics market segmentation by technology 2015
Exhibit 10: Global tissue diagnostics market segmentation by technology 2020
Exhibit 11: Global tissue diagnostics market segmentation by technology 2015-2020
Exhibit 12: Global tissue diagnostics market segmentation by advanced staining 2015
Exhibit 13: Global tissue diagnostics market segmentation by advanced staining 2020
Exhibit 14: Global tissue diagnostics market segmentation by advanced staining 2015-2020
Exhibit 15: Global tissue diagnostics market by IHC 2015-2020 ($ billions)
Exhibit 16: Global tissue diagnostics market by ISH 2015-2020 ($ millions)
Exhibit 17: Types of ISH
Exhibit 18: Comparative analysis of CISH, FISH, and IHC
Exhibit 19: Global tissue diagnostics market by advanced staining 2015-2020 ($ billions)
Exhibit 20: Geographical segmentation of global tissue diagnostics market by advanced staining 2015
Exhibit 21: Global tissue diagnostics market by digital pathology 2015-2020 ($ billions)
Exhibit 22: Geographical segmentation of global tissue diagnostics market by digital pathology 2015
Exhibit 23: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015
Exhibit 24: Global tissue diagnostics market segmentation by preanalytical and routine staining 2020
Exhibit 25: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015-2020
Exhibit 26: Global tissue diagnostics market by preanalytical staining 2015-2020 ($ millions)
Exhibit 27: Global tissue diagnostics market by H&E staining 2015-2020 ($ millions)
Exhibit 28: Common special stains used for histological studies
Exhibit 29: Global tissue diagnostics market by special staining 2015-2020 ($ millions)
Exhibit 30: Global tissue diagnostics market by preanalytical and routine staining 2015-2020 ($ billions)
Exhibit 31: Geographical segmentation of global tissue diagnostics market by preanalytical and routine staining 2015
Exhibit 32: Global tissue diagnostics market segmentation by product
Exhibit 33: Global tissue diagnostics market segmentation by product 2015
Exhibit 34: Global tissue diagnostics market segmentation by product 2020
Exhibit 35: Global tissue diagnostics market segmentation by product 2015-2020
Exhibit 36: Global tissue diagnostics market by consumables 2015-2020 ($ billions)
Exhibit 37: Global tissue diagnostics market by instruments 2015-2020 ($ billions)
Exhibit 38: Global tissue diagnostics market segmentation by disease
Exhibit 39: Global tissue diagnostics market segmentation by disease type 2015
Exhibit 40: Global tissue diagnostics market segmentation by end-user
Exhibit 41: Global tissue diagnostics market segmentation by end-user 2015
Exhibit 42: Global tissue diagnostics market segmentation by geography 2015
Exhibit 43: Global tissue diagnostics market segmentation by geography 2020
Exhibit 44: Global tissue diagnostics market segmentation by geography 2015-2020
Exhibit 45: Tissue diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 46: Segmentation of tissue diagnostics market in Americas by technology 2015
Exhibit 47: Tissue diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 48: Segmentation of tissue diagnostics market in EMEA by technology 2015
Exhibit 49: Tissue diagnostics market in APAC 2015-2020 ($ millions)
Exhibit 50: Segmentation of tissue diagnostics market in APAC by technology 2015
Exhibit 51: Impact of drivers
Exhibit 52: Impact of drivers and challenges
Exhibit 53: Ranking of top vendors 2015
Exhibit 54: Roche Diagnostics: Key takeaways
Exhibit 55: Agilent Technologies: Key takeaways
Exhibit 56: Danaher: Key takeaways
Exhibit 57: Abbott Diagnostics: Key takeaways



【掲載企業】

Abbott Diagnostics, Agilent Technologies (a parent company of Dako), Danaher (a parent company of Leica Biosystems), Roche Diagnostics, 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Affymetrix, Agendia, AutoGenomics, AVIVA BioSciences, Biocare Medical, Biocartis, Cancer Genetics, ELITechGroup, Enzo Biochem, Epic Sciences, Fluidigm, HORIBA Medical, Janssen Diagnostics, Olympus Diagnostics Systems Group, Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US), Oxford Gene Technology, PANAGENE, Protea Biosciences Group, Sakura Finetek

【レポートのキーワード】

組織検査、乳がん、肺がん、胃がん、デジタルパソロジー、がん診断、がん検査、医療、組織診断、組織検査装置、消耗品

【リサーチ方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[組織検査の世界市場2016-2020]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆